default author photo

Michiel S. van der Heijden

Netherlands Cancer Institute - Division of Molecular Carcinogenesis

Netherlands Cancer Institute - Division of Medical Oncology

Amsterdam

Netherlands

SCHOLARLY PAPERS

2

DOWNLOADS

82

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma

Number of pages: 82 Posted: 20 Jul 2021
Erasmus University Medical Center - Department of Urology, Erasmus University Medical Center - Department of Medical Oncology, Erasmus University Medical Center - Cancer Computational Biology Center, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Vrije Universiteit Amsterdam, Cancer Center Amsterdam Department of Medical Oncology, Utrecht University - Cancer Genomics Netherlands, Radboud University Medical Center - Department of Medical Oncology, Radboud University Medical Center - Department of Medical Oncology, University Medical Center Groningen - Department of Medical Oncology, Erasmus MC University Medical Center Rotterdam - Department of Pathology, Amphia Hospital - Department of Internal Mediine, Erasmus MC University Medical Center Rotterdam - Department of Pathology, Erasmus University Medical Center - Department of Medical Oncology, Erasmus University Medical Center - Department of Medical Oncology, Erasmus University Medical Center - Department of Urology & Depratment of Immunology, Erasmus University Medical Center - Department of Urology and Erasmus University Medical Center - Department of Urology
Downloads 48 (1,097,529)

Abstract:

Loading...

Molecular Profiling, Neoplasm Metastases, RNA-seq, Urologic Neoplasms, Whole Genome Sequencing

2.

Enhancer Profiling Identifies Epigenetic Markers of Endocrine Resistance and Reveals Therapeutic Options for Metastatic Castration-Resistant Prostate Cancer Patients

Number of pages: 88 Posted: 13 Mar 2023
Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, University of Washington - Department of Urology, University of Washington - Department of Urology, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, VU University Amsterdam - Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, Netherlands Cancer Institute - Department of Biometrics, Netherlands Cancer Institute - Department of Pathology, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Erasmus University Rotterdam (EUR) - Department of Urology, Erasmus University Rotterdam (EUR) - Department of Pathology, Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, University of Washington - Department of Urology, Netherlands Cancer Institute - Division of Oncogenomics and Netherlands Cancer Institute - Division of Oncogenomics
Downloads 34 (1,277,121)

Abstract:

Loading...

mCRPC, enzalutamide, epigenetics, androgen receptor, H3K27ac, HDAC inhibitors, biomarkers, hormone intervention